Skip to main content
Access Resources

MJFF Publications

4711 - 4720 of 7370 Results
Title
Year
  • Year
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • OPEN
    Title: Ultrasensitive Detection of Aggregated α-Synuclein in Glial Cells, Human Cerebrospinal Fluid, and Brain Tissue Using the RT-QuIC Assay: New High-Throughput Neuroimmune Biomarker Assay for Parkinsonian Disorders
    Journal Name: Journal of Neuroimmune Pharmacology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s11481-019-09835-4
    Citation Count: 63
  • OPEN
    Title: Basic clinical features do not predict dopamine transporter binding in idiopathic REM behavior disorder
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-018-0073-1
    Citation Count: 22
  • OPEN
    Title: Multiancestry Genome-Wide Association Study of Lipid Levels Incorporating Gene-Alcohol Interactions
    Journal Name: American Journal of Epidemiology
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: public-domain, public-domain, public-domain
    DOI - Digital Object Identifier: 10.1093/aje/kwz005
    Citation Count: 85
  • OPEN
    Title: Data-Driven Subtyping of Parkinson’s Disease Using Longitudinal Clinical Records: A Cohort Study
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-018-37545-z
    Citation Count: 83
  • OPEN
    Title: Earlier Dopaminergic Treatment in Parkinson's Disease Is Not Associated With Improved Outcomes
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.12724
    Citation Count: 1
  • RESTRICTED
    Title: Active information storage in Parkinson’s disease: a resting state fMRI study over the sensorimotor cortex
    Journal Name: Brain Imaging and Behavior
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s11682-019-00037-3
    Best OA location URL:
    Citation Count: 4
  • OPEN
    Title: The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27614
    Citation Count: 65
  • OPEN
    Title: Are PARKIN patients ideal candidates for dopaminergic cell replacement therapies?
    Journal Name: European Journal of Neuroscience
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1111/ejn.14314
    Citation Count: 13
  • RESTRICTED
    Title: Targeting the Dopaminergic System in Autoimmunity
    Journal Name: Journal of Neuroimmune Pharmacology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s11481-019-09834-5
    Best OA location URL:
    Citation Count: 46
  • OPEN
    Title: miR-34a: a new player in the regulation of T cell function by modulation of NF-κB signaling
    Journal Name: Cell Death & Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41419-018-1295-1
    Citation Count: 56
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.